Clinical Trials Browser

Phase 1 × Interventional × Hypophosphatemia × Clear all

NCT00622479 2014-12-18

Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.

Phase 1 Terminated

Carcinoma, Renal Cell, Hypophosphatemia